Loading stock data...

NGL Fine-Chem Limited

NSE: NGLFINE BSE: NGLFINE

NSE
1,407.20 -14.10 (-0.99%)

Prev Close

1421.3

Open Price

1418.5

Volume

659

Today Low / High

1394.5 / 1440.3

52 WK Low / High

957 / 2374

Range

1,337 - 1,478

BSE
1,407.05 -10.70 (-0.75%)

Prev Close

1417.75

Open Price

1421.3

Volume

79

Today Low / High

1396 / 1426.85

52 WK Low / High

962.7 / 2355.8

Range

1,337 - 1,477

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1407.2 (target range: 1,337 - 1,478), reflecting a change of -14.1 (-0.99205%). On the BSE, it is listed at 1407.05 (target range: 1,337 - 1,477), showing a change of -10.7 (-0.75472%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

22 Aug 1,418.50 -0.80%
21 Aug 1,451.00 -2.05%
20 Aug 1,428.80 3.07%
19 Aug 1,369.00 4.37%
18 Aug 1,370.00 -0.23%
14 Aug 1,323.40 3.76%
13 Aug 1,380.00 -4.19%
12 Aug 1,226.80 8.99%
11 Aug 1,248.00 -2.31%
08 Aug 1,229.50 -2.03%
07 Aug 1,234.90 -0.45%
06 Aug 1,260.50 -3.03%
05 Aug 1,299.00 -2.96%
04 Aug 1,373.90 -6.82%
01 Aug 1,345.90 -2.44%
31 Jul 1,274.00 3.16%
30 Jul 1,249.00 2.00%
29 Jul 1,203.00 0.96%
28 Jul 1,269.10 -1.94%

NGL Fine-Chem Limited Graph

NGL Fine-Chem Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for NGL Fine-Chem Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,407.20, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,407.05 1,421.12 1,279.01 - 1,563.23
1,435.19 1,148.15 - 1,722.23
1,449.26 1,014.48 - 1,884.04
Bearish Scenario 1,407.05 1,392.98 1,253.68 - 1,532.28
1,378.91 1,103.13 - 1,654.69
1,364.84 955.39 - 1,774.29

Overview of NGL Fine-Chem Limited

ISIN

INE887E01022

Industry

Drug Manufacturers - General

Vol.Avg

2,186

Market Cap

8,693,709,744

Last Dividend

1.75

Official Website

Visit Website

IPO Date

2022-07-08

DCF Diff

1,711.97

DCF

-672

Financial Ratios Every Investor Needs

Stock Dividend of NGLFINE

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-08-12 August 12, 25 1.75 1.75 2025-08-12 2025-08-26
2024-08-16 August 16, 24 1.75 1.75 2024-08-16 2024-09-22
2023-08-17 August 17, 23 1.75 1.75 2023-08-18 2023-09-24
2022-06-22 June 22, 22 1.75 1.75 2022-06-23 2022-07-30
2021-08-12 August 12, 21 1.75 1.75 2021-08-13 2021-09-19

Stock Rating Details for NGLFINE

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 368.26 Cr 182.41 Cr 185.85 Cr 0.5047 5.02 Cr 7.06 Cr 130.30 Cr 21.12 Cr 34.19 33.87 Cr 0.0574
2024-03-31 333.71 Cr 270.06 Cr 63.65 Cr 0.1907 7.76 Cr 6.21 Cr 41.63 Cr 41.32 Cr 66.88 67.87 Cr 0.1238
2023-03-31 278.08 Cr 140.32 Cr 137.76 Cr 0.4954 5.32 Cr 38.49 Cr 23.03 Cr 20.50 Cr 33.18 40.49 Cr 0.0737
2022-03-31 312.83 Cr 146.99 Cr 165.84 Cr 0.5301 4.27 Cr 3.84 Cr 57.48 Cr 49.90 Cr 80.77 78.88 Cr 0.1595
2021-03-31 255.00 Cr 102.34 Cr 152.66 Cr 0.5987 3.28 Cr 3.26 Cr 75.96 Cr 56.72 Cr 91.81 88.13 Cr 0.2224

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 5.86 Cr 433.39 Cr 150.96 Cr 282.4346 Cr 73.15 Cr 67.29 Cr 51.27 Cr 191.85 Cr 0.00 Cr 0.00 Cr 1.00 Cr 118.9700 Cr
2024-03-31 0.40 Cr 355.54 Cr 92.90 Cr 262.6319 Cr 34.00 Cr 33.61 Cr 43.30 Cr 130.82 Cr 0.00 Cr 0.00 Cr 4.62 Cr 86.5872 Cr
2023-03-31 7.83 Cr 287.08 Cr 64.53 Cr 222.5491 Cr 30.48 Cr 22.65 Cr 26.99 Cr 113.90 Cr 5.30 Cr 2.70 Cr 4.39 Cr 58.2917 Cr
2022-03-31 0.64 Cr 276.93 Cr 73.71 Cr 203.2179 Cr 30.00 Cr 29.36 Cr 56.01 Cr 94.75 Cr 1.93 Cr 2.55 Cr 2.57 Cr 65.6504 Cr
2021-03-31 2.10 Cr 207.77 Cr 53.31 Cr 154.4578 Cr 16.45 Cr 14.35 Cr 37.85 Cr 75.98 Cr 2.29 Cr 2.46 Cr -27.11 Cr 42.1431 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 35.8221 Cr -34.5528 Cr -1.0812 Cr -94.9494 Cr 0.1881 Cr 0.5833 Cr -130.7715 Cr 21.1243 Cr 40.7110 Cr -1.0812 Cr -7.9666 Cr
2024-03-31 20.4653 Cr -26.8173 Cr -1.0812 Cr -8.0588 Cr -7.4332 Cr 0.3952 Cr -28.5241 Cr 41.3167 Cr 0.0000 Cr -1.0812 Cr -16.3102 Cr
2023-03-31 35.2862 Cr -27.0204 Cr -1.0812 Cr 3.8795 Cr 7.1846 Cr 7.8284 Cr -31.4067 Cr 27.3620 Cr 0.0000 Cr -1.0812 Cr 29.0143 Cr
2022-03-31 13.8246 Cr -14.2030 Cr -1.0812 Cr -42.5518 Cr -1.4595 Cr 0.6438 Cr -56.3764 Cr 66.5964 Cr 0.0000 Cr -1.0812 Cr -18.1570 Cr
2021-03-31 27.3541 Cr -24.5685 Cr -1.0812 Cr 10.1422 Cr 1.7044 Cr 2.1033 Cr -17.2119 Cr 77.5895 Cr 0.0000 Cr -1.0812 Cr -9.9537 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 104.19 Cr 51.89 Cr 52.29 Cr 0.5019 6.71 Cr 9.24 Cr 14.96 17.33 Cr 0.0887
2025-03-31 94.97 Cr 47.80 Cr 47.17 Cr 0.4967 32.92 Cr 0.54 Cr 0.88 6.11 Cr 0.0057
2024-12-31 89.10 Cr 43.53 Cr 45.57 Cr 0.5115 2.00 Cr 1.27 Cr 2.07 4.96 Cr 0.0143
2024-09-30 93.48 Cr 44.18 Cr 49.31 Cr 0.5275 8.53 Cr 9.81 Cr 15.88 16.67 Cr 0.1050
2024-06-30 90.75 Cr 62.09 Cr 28.66 Cr 0.3158 31.66 Cr 9.22 Cr 14.92 9.35 Cr 0.1016

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 5.86 Cr 59.66 Cr 65.53 Cr 81.55 Cr 51.27 Cr 235.38 Cr 191.85 Cr 433.39 Cr 150.96 Cr
2024-12-31 0.00 Cr 0.00 Cr 98.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -280.29 Cr
2024-09-30 6.00 Cr 92.99 Cr 98.99 Cr 75.28 Cr 43.46 Cr 235.28 Cr 149.37 Cr 395.85 Cr 115.56 Cr
2024-06-30 0.00 Cr 0.00 Cr 55.31 Cr 0.00 Cr 0.00 Cr 55.31 Cr 0.00 Cr 0.00 Cr -262.63 Cr
2024-03-31 1.72 Cr 53.59 Cr 55.31 Cr 90.37 Cr 43.30 Cr 212.67 Cr 130.82 Cr 355.54 Cr 92.90 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 0.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 1.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 9.81 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 9.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 12.30 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Drug Manufacturers - General

Company Name Symbol Price Market Cap Volume
Cipla Limited CIPLA ₹1,592.80 ₹1,286,590,545,715.00 ₹1,574,525.00
Abbott India Limited ABBOTINDIA ₹31,875.00 ₹677,321,437,500.00 ₹6,991.00
GlaxoSmithKline Pharmaceuticals Limited GLAXO ₹2,798.80 ₹474,133,512,800.00 ₹39,428.00
Gland Pharma Limited GLAND ₹1,957.40 ₹322,493,394,400.00 ₹430,192.00
Pfizer Limited PFIZER ₹5,668.50 ₹259,320,837,450.00 ₹24,713.00
Sanofi India Limited SANOFI ₹5,230.50 ₹120,458,415,000.00 ₹7,436.00
Marksans Pharma Limited MARKSANS ₹179.96 ₹81,551,393,440.00 ₹681,593.00

Key Executives

Whole Time Director & Chief Financial Officer
Mr. Rajesh Narayan Lawande

Gender: male

Year Born: 1976

Chief Executive Officer, MD, Chief Ethics Counsellor & Executive Director
Mr. Rahul Jayant Nachane

Gender: male

Year Born: 1964

Company Secretary & Compliance Officer
Ms. Pallavi Pednekar

Gender: female

Year Born:

Vice President
Mr. Ahaan Nachane

Gender: male

Year Born:

FAQs about NGL Fine-Chem Limited

Who is the CEO of the company?

The CEO is Rahul Jayant Nachane.

What is the current market price of the stock?

The current price is ₹1,407.20.

What is the 52-week price range?

The range is ₹957-2374.

What is the market capitalization of the company?

The market capitalization is ₹869.37 crores.

What is the dividend yield?

The dividend yield is 0.12%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 41.65.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of NGL Fine-Chem Limited (ISIN: INE887E01022) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹869.37 crores and an average daily volume of 2,186 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹1.75.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack